Southwest Kidney Davita Dialysis Partners, Llc is a medicare approved dialysis facility center in Fountain Hills, Arizona and it has 12 dialysis stations. It is located in Maricopa county at 13430 N Saguaro Blvd, Fountain Hills, AZ, 85268. You can reach out to the office of Southwest Kidney Davita Dialysis Partners, Llc at (480) 816-5973. This dialysis clinic is managed and/or owned by Davita. Southwest Kidney Davita Dialysis Partners, Llc has the following ownership type - Profit. It was first certified by medicare in March, 2016. The medicare id for this facility is 032645 and it accepts patients under medicare ESRD program.
| Name | Southwest Kidney Davita Dialysis Partners, Llc |
|---|---|
| Location | 13430 N Saguaro Blvd, Fountain Hills, Arizona |
| No. of Dialysis Stations | 12 |
| Medicare ID | 032645 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 13430 N Saguaro Blvd, Fountain Hills, Arizona, 85268 | |
| (480) 816-5973 | |
News Archive
Surprisingly, exposure to a high background radiation might actually lead to clear beneficial health effects in humans, according to Ben-Gurion University of the Negev and Nuclear Research Center Negev scientists.
Second Sight Medical Products, Inc., a developer, manufacturer and marketer of implantable visual prosthetics to provide useful vision to blind patients, today announced that the Company has received conditional approval from the U.S. Food and Drug Administration to begin the Orion™ Cortical Visual Prosthesis System feasibility clinical study.
Araim Pharmaceuticals has formed a long-term strategic partnership with Vault Bioventures to facilitate the advancement to market of its novel peptide library which targets devastating injuries and chronic diseases underserved by current therapies.
LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 19,066 procedures were performed during the first quarter of 2010. This compares with 27,859 procedures (75 vision centers) and 25,232 same-store procedures (62 vision centers) performed during the first quarter of 2009.
› Verified 4 days ago
| NPI Number | 1427434687 |
| Organization Name | Fountain Hills Dialysis |
| Doing Business As | Southwest Kidney-davita Dialysis Partners, Llc |
| Address | 13430 N Saguaro Blvd Fountain Hills, Arizona, 85268 |
| Phone Number | (480) 816-5973 |
News Archive
Surprisingly, exposure to a high background radiation might actually lead to clear beneficial health effects in humans, according to Ben-Gurion University of the Negev and Nuclear Research Center Negev scientists.
Second Sight Medical Products, Inc., a developer, manufacturer and marketer of implantable visual prosthetics to provide useful vision to blind patients, today announced that the Company has received conditional approval from the U.S. Food and Drug Administration to begin the Orion™ Cortical Visual Prosthesis System feasibility clinical study.
Araim Pharmaceuticals has formed a long-term strategic partnership with Vault Bioventures to facilitate the advancement to market of its novel peptide library which targets devastating injuries and chronic diseases underserved by current therapies.
LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 19,066 procedures were performed during the first quarter of 2010. This compares with 27,859 procedures (75 vision centers) and 25,232 same-store procedures (62 vision centers) performed during the first quarter of 2009.
› Verified 4 days ago
| Dialysis patients with Hemoglobin data | 7 |
News Archive
Surprisingly, exposure to a high background radiation might actually lead to clear beneficial health effects in humans, according to Ben-Gurion University of the Negev and Nuclear Research Center Negev scientists.
Second Sight Medical Products, Inc., a developer, manufacturer and marketer of implantable visual prosthetics to provide useful vision to blind patients, today announced that the Company has received conditional approval from the U.S. Food and Drug Administration to begin the Orion™ Cortical Visual Prosthesis System feasibility clinical study.
Araim Pharmaceuticals has formed a long-term strategic partnership with Vault Bioventures to facilitate the advancement to market of its novel peptide library which targets devastating injuries and chronic diseases underserved by current therapies.
LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 19,066 procedures were performed during the first quarter of 2010. This compares with 27,859 procedures (75 vision centers) and 25,232 same-store procedures (62 vision centers) performed during the first quarter of 2009.
› Verified 4 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 25 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 176 |
| Percentage of adult patients getting regular hemodialysis at the center | 92 |
News Archive
Surprisingly, exposure to a high background radiation might actually lead to clear beneficial health effects in humans, according to Ben-Gurion University of the Negev and Nuclear Research Center Negev scientists.
Second Sight Medical Products, Inc., a developer, manufacturer and marketer of implantable visual prosthetics to provide useful vision to blind patients, today announced that the Company has received conditional approval from the U.S. Food and Drug Administration to begin the Orion™ Cortical Visual Prosthesis System feasibility clinical study.
Araim Pharmaceuticals has formed a long-term strategic partnership with Vault Bioventures to facilitate the advancement to market of its novel peptide library which targets devastating injuries and chronic diseases underserved by current therapies.
LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 19,066 procedures were performed during the first quarter of 2010. This compares with 27,859 procedures (75 vision centers) and 25,232 same-store procedures (62 vision centers) performed during the first quarter of 2009.
› Verified 4 days ago
| Adult patients getting regular peritoneal dialysis at the center | 9 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 34 |
News Archive
Surprisingly, exposure to a high background radiation might actually lead to clear beneficial health effects in humans, according to Ben-Gurion University of the Negev and Nuclear Research Center Negev scientists.
Second Sight Medical Products, Inc., a developer, manufacturer and marketer of implantable visual prosthetics to provide useful vision to blind patients, today announced that the Company has received conditional approval from the U.S. Food and Drug Administration to begin the Orion™ Cortical Visual Prosthesis System feasibility clinical study.
Araim Pharmaceuticals has formed a long-term strategic partnership with Vault Bioventures to facilitate the advancement to market of its novel peptide library which targets devastating injuries and chronic diseases underserved by current therapies.
LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 19,066 procedures were performed during the first quarter of 2010. This compares with 27,859 procedures (75 vision centers) and 25,232 same-store procedures (62 vision centers) performed during the first quarter of 2009.
› Verified 4 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Southwest Kidney Davita Dialysis Partners, Llc with elevated calcium levels.
| Patients with hypercalcemia | 34 |
| Hypercalcemia patient months | 210 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 2 |
| Patients with Serumphosphor | 34 |
| Patients with Serumphosphor less than 3.5 mg/dL | 9 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 29 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 34 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 18 |
| Patients with Serumphosphor greater than 7 mg/dL | 9 |
News Archive
Surprisingly, exposure to a high background radiation might actually lead to clear beneficial health effects in humans, according to Ben-Gurion University of the Negev and Nuclear Research Center Negev scientists.
Second Sight Medical Products, Inc., a developer, manufacturer and marketer of implantable visual prosthetics to provide useful vision to blind patients, today announced that the Company has received conditional approval from the U.S. Food and Drug Administration to begin the Orion™ Cortical Visual Prosthesis System feasibility clinical study.
Araim Pharmaceuticals has formed a long-term strategic partnership with Vault Bioventures to facilitate the advancement to market of its novel peptide library which targets devastating injuries and chronic diseases underserved by current therapies.
LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 19,066 procedures were performed during the first quarter of 2010. This compares with 27,859 procedures (75 vision centers) and 25,232 same-store procedures (62 vision centers) performed during the first quarter of 2009.
› Verified 4 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 30 |
| Patient months included in arterial venous fistula and catheter summaries | 106 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 89 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 7 |
News Archive
Surprisingly, exposure to a high background radiation might actually lead to clear beneficial health effects in humans, according to Ben-Gurion University of the Negev and Nuclear Research Center Negev scientists.
Second Sight Medical Products, Inc., a developer, manufacturer and marketer of implantable visual prosthetics to provide useful vision to blind patients, today announced that the Company has received conditional approval from the U.S. Food and Drug Administration to begin the Orion™ Cortical Visual Prosthesis System feasibility clinical study.
Araim Pharmaceuticals has formed a long-term strategic partnership with Vault Bioventures to facilitate the advancement to market of its novel peptide library which targets devastating injuries and chronic diseases underserved by current therapies.
LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 19,066 procedures were performed during the first quarter of 2010. This compares with 27,859 procedures (75 vision centers) and 25,232 same-store procedures (62 vision centers) performed during the first quarter of 2009.
› Verified 4 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 16 |
| Hospitalization Rate in facility | 191.9 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 693.9 |
| Hospitalization Rate: Lower Confidence Limit | 58.8 |
News Archive
Surprisingly, exposure to a high background radiation might actually lead to clear beneficial health effects in humans, according to Ben-Gurion University of the Negev and Nuclear Research Center Negev scientists.
Second Sight Medical Products, Inc., a developer, manufacturer and marketer of implantable visual prosthetics to provide useful vision to blind patients, today announced that the Company has received conditional approval from the U.S. Food and Drug Administration to begin the Orion™ Cortical Visual Prosthesis System feasibility clinical study.
Araim Pharmaceuticals has formed a long-term strategic partnership with Vault Bioventures to facilitate the advancement to market of its novel peptide library which targets devastating injuries and chronic diseases underserved by current therapies.
LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 19,066 procedures were performed during the first quarter of 2010. This compares with 27,859 procedures (75 vision centers) and 25,232 same-store procedures (62 vision centers) performed during the first quarter of 2009.
› Verified 4 days ago
The rate of readmission show you whether patients who were being treated regularly at Southwest Kidney Davita Dialysis Partners, Llc were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 6.3 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 28.6 |
| Readmission Rate: Lower Confidence Limit | .2 |
News Archive
Surprisingly, exposure to a high background radiation might actually lead to clear beneficial health effects in humans, according to Ben-Gurion University of the Negev and Nuclear Research Center Negev scientists.
Second Sight Medical Products, Inc., a developer, manufacturer and marketer of implantable visual prosthetics to provide useful vision to blind patients, today announced that the Company has received conditional approval from the U.S. Food and Drug Administration to begin the Orion™ Cortical Visual Prosthesis System feasibility clinical study.
Araim Pharmaceuticals has formed a long-term strategic partnership with Vault Bioventures to facilitate the advancement to market of its novel peptide library which targets devastating injuries and chronic diseases underserved by current therapies.
LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 19,066 procedures were performed during the first quarter of 2010. This compares with 27,859 procedures (75 vision centers) and 25,232 same-store procedures (62 vision centers) performed during the first quarter of 2009.
› Verified 4 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Southwest Kidney Davita Dialysis Partners, Llc's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 8 |
News Archive
Surprisingly, exposure to a high background radiation might actually lead to clear beneficial health effects in humans, according to Ben-Gurion University of the Negev and Nuclear Research Center Negev scientists.
Second Sight Medical Products, Inc., a developer, manufacturer and marketer of implantable visual prosthetics to provide useful vision to blind patients, today announced that the Company has received conditional approval from the U.S. Food and Drug Administration to begin the Orion™ Cortical Visual Prosthesis System feasibility clinical study.
Araim Pharmaceuticals has formed a long-term strategic partnership with Vault Bioventures to facilitate the advancement to market of its novel peptide library which targets devastating injuries and chronic diseases underserved by current therapies.
LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 19,066 procedures were performed during the first quarter of 2010. This compares with 27,859 procedures (75 vision centers) and 25,232 same-store procedures (62 vision centers) performed during the first quarter of 2009.
› Verified 4 days ago
The rate of mortality show you whether patients who were being treated regularly at Southwest Kidney Davita Dialysis Partners, Llc lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 26 |
News Archive
Surprisingly, exposure to a high background radiation might actually lead to clear beneficial health effects in humans, according to Ben-Gurion University of the Negev and Nuclear Research Center Negev scientists.
Second Sight Medical Products, Inc., a developer, manufacturer and marketer of implantable visual prosthetics to provide useful vision to blind patients, today announced that the Company has received conditional approval from the U.S. Food and Drug Administration to begin the Orion™ Cortical Visual Prosthesis System feasibility clinical study.
Araim Pharmaceuticals has formed a long-term strategic partnership with Vault Bioventures to facilitate the advancement to market of its novel peptide library which targets devastating injuries and chronic diseases underserved by current therapies.
LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 19,066 procedures were performed during the first quarter of 2010. This compares with 27,859 procedures (75 vision centers) and 25,232 same-store procedures (62 vision centers) performed during the first quarter of 2009.
› Verified 4 days ago
Southwest Kidney Davita Dialysis Partners, Llc Location: 13430 N Saguaro Blvd, Fountain Hills, Arizona, 85268 Phone: (480) 816-5973 |
News Archive
Surprisingly, exposure to a high background radiation might actually lead to clear beneficial health effects in humans, according to Ben-Gurion University of the Negev and Nuclear Research Center Negev scientists.
Second Sight Medical Products, Inc., a developer, manufacturer and marketer of implantable visual prosthetics to provide useful vision to blind patients, today announced that the Company has received conditional approval from the U.S. Food and Drug Administration to begin the Orion™ Cortical Visual Prosthesis System feasibility clinical study.
Araim Pharmaceuticals has formed a long-term strategic partnership with Vault Bioventures to facilitate the advancement to market of its novel peptide library which targets devastating injuries and chronic diseases underserved by current therapies.
LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 19,066 procedures were performed during the first quarter of 2010. This compares with 27,859 procedures (75 vision centers) and 25,232 same-store procedures (62 vision centers) performed during the first quarter of 2009.
› Verified 4 days ago